Increasing illness severity in very low birth weight infants over a 9-year period by Paul, David A et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Pediatrics
Open Access Research article
Increasing illness severity in very low birth weight infants over a 
9-year period
David A Paul*1,2, Kathleen H Leef1, Robert G Locke1,2, Louis Bartoshesky2, 
Judy Walrath3 and John L Stefano1,2
Address: 1Department of Pediatrics, Section of Neonatology, Christiana Care Health Services, Newark, DE, USA. , 2Department of Pediatrics, 
duPont Hospital for Children, Wilmington, DE, USA. Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA, USA and 3Eugene 
duPont, Preventive Medicine and Rehabilitation Institute, Christiana Care Health Services, Newark, DE, USA
Email: David A Paul* - paul.d@christianacare.org; Kathleen H Leef - kleef@christianacare.org; Robert G Locke - rlocke@christianacare.org; 
Louis Bartoshesky - lbartosh@nemours.org; Judy Walrath - jwalrath@christianacare.org; John L Stefano - jstefano@christianacare.org
* Corresponding author    
Abstract
Background: Recent reports have documented a leveling-off of survival rates in preterm infants
through the 1990's. The objective of this study was to determine temporal changes in illness
severity in very low birth weight (VLBW) infants in relationship to the outcomes of death and/or
severe IVH.
Methods: Cohort study of 1414 VLBW infants cared for in a single level III neonatal intensive care
unit in Delaware from 1993–2002. Infants were divided into consecutive 3-year cohorts. Illness
severity was measured by two objective methods: the Score for Neonatal Acute Physiology
(SNAP), based on data from the 1st day of life, and total thyroxine (T4), measured on the 5th day of
life. Death before hospital discharge and severe intraventricular hemorrhage (IVH) were
investigated in the study sample in relation to illness severity. The fetal death rate was also
investigated. Statistical analyses included both univariate and multivariate analysis.
Results: Illness severity, as measured by SNAP and T4, increased steadily over the 9-year study
period with an associated increase in severe IVH and the combined outcome of death and/or
severe IVH. During the final 3 years of the study, the observed increase in illness severity accounted
for 86% (95% CI 57–116%) of the variability in the increase in death and/or severe IVH. The fetal
death rate dropped from 7.8/1000 (1993–1996) to 5.3/1000 (1999–2002, p = .01) over the course
of the study.
Conclusion: These data demonstrate a progressive increase in illness in VLBW infants over time,
associated with an increase in death and/or severe IVH. We speculate that the observed decrease
in fetal death, and the increase in neonatal illness, mortality and/or severe IVH over time represent
a shift of severely compromised patients that now survive the fetal time period and are presented
for care in the neonatal unit.
Published: 06 February 2006
BMC Pediatrics2006, 6:2 doi:10.1186/1471-2431-6-2
Received: 11 August 2005
Accepted: 06 February 2006
This article is available from: http://www.biomedcentral.com/1471-2431/6/2
© 2006Paul et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pediatrics 2006, 6:2 http://www.biomedcentral.com/1471-2431/6/2
Page 2 of 8
(page number not for citation purposes)
Background
Despite continuing advances in neonatal care and decades
of improving outcomes, it has recently been reported that
survival rates have leveled-off in premature infants during
the 1990s [1-3]. In the state of Delaware, infant mortality
rates improved during the early 1990s similar to national
trends, only to see a more recent increase which has been
attributed to increasing mortality in very low birth weight
infants [4]. In the United States, infant mortality increased
in 2002 for the first time in nearly 5 decades [5,6]. In 2002
the United States fetal mortality rate declined while infant
mortality increased [6]. A shift from fetal to neonatal
deaths is one possible explanation for this trend. The
potential impact of increasing fetal survival on neonatal
intensive care has not been explored.
Severe intraventricular hemorrhage (IVH) is a significant
morbidity in premature infants and is one of the major
determinants of long term outcome in very low birth
weight infants [7]. Severe IVH has recently shown to have
declined in occurrence prior to the 1990's and to have
remained unchanged thereafter [8]. Other common mor-
bidities in premature infants including chronic lung dis-
ease have also been recently described as increasing in
survivors [9]. The reasons for increasing morbidities and
recent lack of improvement in survival rates of preterm
infants have not been conclusively explained. It has been
postulated that the technology for caring for premature
infants has reached it limits. One factor that has yet to be
investigated is the longitudinal effect of illness severity on
morbidity and mortality in premature infants. We
hypothesized that illness severity in very low birth weight
(VLBW) infants was increasing over time. The objectives
of this study were to investigate whether illness was
increasing over time and to determine the effect of illness
severity on the outcomes of death and/or severe IVH in a
population of VLBW infants. As the fetal mortality rate has
been declining in the United States [6], and may be lead-
ing to a shift from fetal death to physiologically compro-
mised preterm infants, we also explored the fetal death
rate at our institution during the study time period.
Methods
This investigation consisted of a cohort study of VLBW
infants, <1500 grams, cared for at a single level III Neona-
tal Intensive Care Unit (NICU) during a 9-year period,
July 1993–July 2002, n = 1414. The NICU at Christiana
Hospital is a level III NICU serving the state of Delaware
and cares for both inborn (90%) and outborn infants.
Neonatal care within the State of Delaware is regional-
ized. One other level III NICU in the same network serves
as a referral center for VLBW infants only if they require
surgical care. No other nursery in the State offers intensive
care for preterm infants with birth weights <1250 grams.
A small number of infants with birthweight between
1250–1500 grams are cared for at two other level II sites
within the same state neonatal network. There were no
changes in the number of hospitals providing neonatal
intensive care during the study time period. The NICU at
Christiana Hospital is university affiliated and staffed by
residents in pediatrics, neonatal nurse practitioners, and
fellows in neonatal/perinatal medicine in addition to
attending neonatologists. Decisions concerning resusci-
tating babies at the limits of viability are made by the
attending neonatologist after family consultation. In gen-
eral, infants 23 to 24 weeks gestation are offered a trial of
intensive-care if desired by the family following consulta-
tion. This policy did not change during the study period.
Throughout the study period Christiana Hospital was the
only hospital in the state offering perinatology services
and high risk obstetrical care. The Institutional Review
Board at Christiana Care Health Services approved this
research project. Data were obtained from a computerized
database and review of the medical record. Informed writ-
ten consent was not obtained.
Illness severity was quantified using two objective meth-
ods: the Score for Neonatal Physiology (SNAP) [10] and
total thyroxine (T4). SNAP was routinely calculated after
1996 and therefore was available on infants born after
1996. SNAP was calculated on physiologic data from the
1st 24 hours of life. T4 was obtained from the State of Del-
aware Newborn Screening Program and used as a proxy
for illness severity. We, and others, have previously shown
that total T4 is correlated with illness severity in VLBW
infants [11-13]. T4 was obtained on the 5th day of life as
part of routine newborn screening. Therefore, infants who
died before the 5th day of life did not have a measurement
of T4. The mean ± SD of total T4 in infants in the State of
Delaware during the study period was 13.1 ± 4.2 μg/dl. In
order to analyze outcome over time, the study sample was
subdivided into consecutive three-year cohorts. Cohort 1
included infants born 7/93–7/96, Cohort 2, 7/96–7/99,
and Cohort 3, 7/99–7/02.
Cranial ultrasounds were routinely obtained on the 4th
day of life and then monthly until discharge. Cranial
ultrasounds were obtained more frequently if clinically
indicated. Ultrasounds were done using a 7.5 mHZ trans-
ducer and studies were interpreted by a pediatric radiolo-
gist. IVH was graded using the classification system of
Papile [14]. Severe IVH was considered grade III-IV. Ges-
tational age was based on the best obstetrical estimate.
Modified Ballard exam was used only if an obstetrical esti-
mate was not available [15].
A fetal death was defined as any fetus ≥ 20 weeks of gesta-
tion that was not live-born. No policy changes in the def-
inition for classifying fetal death were made throughout
the study period. Fetal death rate is reported per 1000BMC Pediatrics 2006, 6:2 http://www.biomedcentral.com/1471-2431/6/2
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births plus fetal deaths. Mothers were classified as receiv-
ing steroids if they received any doses of antenatal ster-
oids. Betamethasone is the steroid used routinely at our
institution. Clinical chorioamnionitis was diagnosed by
the attending obstetrician, based on the presence of fever,
uterine tenderness and/or foul smelling amniotic fluid.
Any pregnancy with two or more fetuses was considered
multiple-gestation. As infertility and in vitro fertilization
have been increasing during the study period [16], infer-
tility was investigated as an independent variable. For the
purposes of this study, mothers were classified as having a
history of infertility if their infants were conceived by in-
vitro fertilization or if they received ovulation-enhancing
medications such as clomiphene citrate. Mothers were
classified as having preeclampsia if given the diagnosis by
the attending obstetrician per ACOG guidelines [17]. Oli-
gohydramnios was diagnosed by the attending obstetri-
cian, no criteria for a minimal amniotic fluid index was
used as it was not regularly available in the medical
record. Prolonged rupture of membranes was considered
greater than 24 hours. Maternal age was based on age at
time of birth. Infants with birth weight < 1000 grams were
analyzed as a sub-group.
Statistical analyses included both univariate and multivar-
iate analysis. Univariate analysis included chi-squared for
categorical variables, and analysis of variance for continu-
ous variables with normal distribution. Levene's test of
homogeneity of variances was used to assess data distribu-
tion. Mann-Whitney U test was used for continuous vari-
ables that were not normally distributed. Kruskal-Wallis
ANOVA was also used to compare ordinal data over time.
Pearson correlation was used to compare two continuous
variables. Multivariate analysis included logistic regres-
Table 1: Distribution of birthweights in the study cohorts. Distribution of birthweights did not differ between Cohorts.
Birthweight
<500 grams
Birthweight
500–749 grams
Birthweight
750–999 grams
Birthweight
1000–1249 grams
Birthweight
1250–1500 grams
Cohort 1 1993–1996 2% 19% 22% 26% 31%
Cohort 2 1996–1999 2% 15% 24% 30% 29%
Cohort 3 1999–2002 2% 18% 25% 27% 28%
Table 2: Changes in demographics and outcomes over time in the overall population.
Cohort 1 1993–1996 n = 393 Cohort 2 1996–1999 n = 485 Cohort 3 1999–2002 n = 536
Birthweight (g) 1052 ± 297 1057 ± 277 1028 ± 284
Gestational Age (weeks) 28.3 ± 3.0 28.4 ± 2.9 27.8 ± 2.9 * †
Maternal age (years) 26.5 ± 5.9 26.6 ± 6.3 26.7 ± 6.7
Inborn 91% 88% 87%
Apgar score at 5 minutes (median, 
interquartile range)
8 (6–9) 8 (7–9) 8 (7–9)
Apgar score at 5 minutes <5 13% 8% 10%
Cesarean delivery 55% 57% 62% *
Antenatal steroids 48% ‡ 66% 65% *
Antenatal antibiotics 34% ‡ 50% 51% *
Preeclampsia 14% ‡ 20% 24% *
HELLP syndrome 5% 4% 3%
Oligohydramnios 14% 11% 13%
Clinical chorioamnionitis 9% 7% 8%
Maternal fever 4% 2% 4%
Prolonged rupture of membranes 22% 22% 21%
Illicit maternal drug use 3% 2% 3%
Maternal diabetes 5% 3.5% 5%
Multiple gestation births 24% 24% 28%
Infertility 10% 7% 10%
Mechanical ventilation 78% 79% 83%
Rescue high frequency ventilation 13% 15% 22% *†
Exogenous surfactant replacement 63% 65% 75% *†
Postnatal dopamine 24% ‡ 31% 35% *
Postnatal dexamethasone 19% ‡ 25% 16% †
*p < .05, Cohort 1v 3
‡p < .05, Cohort 1 vs 2
†p < .05, Cohort 2 vs 3BMC Pediatrics 2006, 6:2 http://www.biomedcentral.com/1471-2431/6/2
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sion and linear regression. The contributions of increased
to death and/or severe IVH were calculated by comparing
observed to predicted death and or IVH during Cohort 3.
Data from the logistic regression models were used to cal-
culate a standarized rate [18] for the outcome of death
and/or severe IVH. A p value < .05 was considered statisti-
cally significant. Statistica (V7.0, Tulsa, OK) was used for
all statistical calculations
Results
A total of 1414 VLBW infants were cared for in the neona-
tal intensive care unit during the 9-year time period and
comprised the study sample. Cohort 1 (1993–1996) con-
sisted of 393 infants; there were 485 infants in Cohort 2
(1996–1999), and 536 in Cohort 3(1999–2002). In the
study sample, 610 infants (43%) were < 1000 grams birth
weight. The proportion of infants with birthweights
<1000 grams, 42%, 41%, and 46% (p = .26) in Cohorts 1,
2, and 3 respectively, did not change over time. The distri-
bution of infants, in 250 gram increments did not differ
between Cohorts (Table 1). Of the 1414 infants, 1207
(85%) survived until the 5th day of life and had a measure-
ment of T4.
Birthweight and maternal age were not different between
the first, second and third cohorts (Table 2). There was a
small but significant decrease in gestational age over time.
There was no difference in the percentage of inborn
infants over time. There was an increased use of antenatal
steroids and antibiotics during the 2nd and  3rd Cohorts
compared to the 1st Cohort. There was also an increased
occurrence of preeclampsia and cesarean delivery over
time. There were no differences in the occurrence of
maternal HELLP syndrome, diabetes, illicit drug use, clin-
ical chorioamnionitis, prolonged rupture of membranes,
oligohydramnios, multiple gestation, or infertility over
time. In the infants in the study sample, there was no
change in the use of mechanical ventilation over time but
the use of rescue high frequency ventilation and surfactant
did increase over time. Because dopamine can inhibit
pituitary hormone production [19], the use of dopamine
and dexamethasone in infants was investigated. The use of
dopamine in infants increased progressively over time
while the use of postnatal dexamethasone increased
between  Cohort 1 and  Cohort 2 then dropped during
Cohort 3.
Postnatal illness severity increased over time, as measured
by total T4 and SNAP (Table 3). Linear regression models
were used to assess the effect of birth cohort on illness
severity. Forward stepwise linear regression was used. Var-
iables entered into the model included those that were sig-
nificant on univariate analysis and variable which are
known confounders for illness severity such as birth-
weight. Birth cohort remained significant in the models
when illness severity was measured using SNAP as the
dependent variable (model r2 = .41, p < .01) and T4 as the
dependent variable (model r2 = .35, p < .01). Other than
birth cohort, gestational age and birthweight were the
only independent variables contributing more to the var-
iability in both models of illness severity. In addition to
gestational age and birthweight, the models controlled for
maternal antibiotics, multiple gestation birth, race, mater-
nal steroids, preeclampsia, cesarean delivery and inborn
status.
There was no difference in the rate of mortality over time
(Table 3). However, those infants who died during Cohort
3, died earlier compared to those infants who died during
both the 1st  and 2nd  Cohorts. There was an observed
increase in both severe IVH and the combined outcome of
death and/or severe IVH over time. In the sub-group of
infants less than 1000 grams, illness severity increased
over time as measured by both SNAP and T4 (Table 4).
Similar to the general study sample, mortality did not
increase over time, but there was an increase in severe IVH
as well as the outcome of death and/or severe IVH in the
infants <1000 g. Table 5 shows changes in T4 and SNAP in
the study cohorts based on 250 gram birthweight incre-
ments. Illness severity decreased with increasing birth-
weight in each cohort (as measured by increasing SNAP
and decreasing T4.) Illness severity increased over time in
each birthweight subgroup as measured by increasing
SNAP. Illness severity, as measured by decreasing T4,
Table 3: Changes in illness severity and outcomes over time
Cohort 1 1993–1996, n = 393 Cohort 2 1996–1999, n = 485 Cohort 3 1999–2002, N = 536
T4 (μg/dl) 7.6 ± 3.8 ‡ 7.0 ± 3.4 6.5 ± 3.9 * †
SNAP NA 11.2 ± 5.8 13.4 ± 7.6 †
Death 14% 13% 16%
Day of death (median, interquartile range) 7 (2–21) 10.5 (2–22) 3 (2–10) * †
Severe IVH 9% 9% 14% * †
Death and/or Severe IVH 18% 19% 26% * †
*p < .05, Cohort 1vs 3
‡p < .05, Cohort 1 vs 2
†p < .05, Cohort 2 vs 3BMC Pediatrics 2006, 6:2 http://www.biomedcentral.com/1471-2431/6/2
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increased over time in each birthweight subgroup, with
the exception of infants 500–750 grams which
approached statistical significance.
Effect of Illness on death and/or severe IVH
The combined rate of death and/or severe IVH was 19% in
Cohorts 1 and  2  combined. Logistic regression models
were created to control for the potential confounding
effects of gestational age and birthweight on illness sever-
ity. After controlling for gestational age alone by logistic
regression, the odds of death and/or severe IVH increased
1.3 (95% CI 1.2–1.5) for every 1 μg/dl drop in total T4.
When birthweight was added to the model along with ges-
tational age, the odds of death and/or severe IVH
increased to a similar degree 1.2 (95% CI 1.1–1.3) for
every 1 μg/dl drop in total T4. Using T4 as a marker for ill-
ness severity, the rate of death and/or severe IVH would
have been predicted to increase to 25% (95% CI 23–27%)
in Cohort 3. The observed rate of death and/or severe IVH
was 26% (Table 3). If the rate of death and/or IVH would
have remained unchanged at 19%, between Cohorts 1 and
3, 102 cases of death and/or IVH would have been
expected (.19 × 536 infants). In fact, 139 cases of death
and/or severe IVH were observed (+37 cases). The
observed increase in illness severity would be expected to
increase the number of cases of death and/or IVH during
Cohort 3 by 32 cases (95% CI 19–43 cases). Thus, 32 of the
37, or 86% (95% CI 57–116%) of the observed increase
in death and/or severe IVH in Cohort 3 could be accounted
for by the observed increase in illness severity observed
during Cohort 3.
Data from the logistic model were also used to calculate a
standardized rate [18]. Standardized rate, a tool used for
quality assurance, was used to evaluate the possibility that
changes in quality of neonatal care were responsible for
the observed changes in outcomes. The standardized rate
compared the observed rate of death and/or severe IVH to
the expected rate of death and or severe IVH based on ill-
ness severity, gestational age, and birthweight. Compared
to the earlier Cohorts, the standardized rate of death and or
severe IVH dropped in Cohort 3 when illness severity was
accounted for using either T4 or SNAP [Figure].
Fetal death rate
During the study period the fetal death rate at Christiana
Hospital decreased over time. The fetal death rate was 7.8/
1000 in Cohort 1, 6.7/1000 in Cohort 2, and 5.3/1000 in
Cohort 3 (p = .01, Cohort 1 vs 3).
Discussion
Our data show an increase in illness severity in VLBW
infants over a 9-year period at a regional level III NICU in
the State of Delaware. During this same time period, there
was an associated decrease in the fetal death rate, and an
increased occurrence in severe IVH. The contribution from
increased illness accounted for a majority of the variability
Table 4: Changes in illness severity and outcomes over time in infants <1000 g
Infants <1000 g Cohort 1 1993–1996, n = 165 Cohort 2 1996–1999, n = 199 Cohort 3 1999–2002, n = 246
T4 (μg/dl) 5.4 ± 2.9 5.3 ± 3.1 4.7 ± 3.3 *
SNAP NA 15.3 ± 7.4 18.3 ± 8.9 †
Death 30% 27% 33%
Severe IVH 16% 14% 23% †
Death/Severe IVH 35% 36% 46% * †
*p < .05, Cohort 1v 3
‡p < .05, Cohort 1 vs 2
†p < .05, Cohort 2 vs 3
Table 5: Illness severity by 250 gram birthweight increments. Data for infants <500 grams are not provided due to small numbers.
Birthweight
500–749 grams
Birthweight
750–999 grams
Birthweight
1000–1249 grams
Birthweight
1250–1500 grams
Birthweight p
T4 (μg/dl)
Cohort 1 1993–1996 4.5 ± 2.3 6.1 ± 3.1 8.0 ± 3.5 9.8 ± 3.6 <.01
Cohort 2 1996–1999 4.3 ± 3.3 5.8 ± 2.9 7.4 ± 2.9 8.9 ± 3.2 <.01
Cohort 3 1999–2002 3.6 ± 2.3 5.0 ± 2.9 6.9 ± 3.7 8.3 ± 3.7 <.01
Cohort, p .20 .03 .04 .03
SNAP
Cohort 2 1996–1999 17.1 ± 6.7 13.6 ± 7.0 10.1 ± 5.0 8.0 ± 4.6 <.01
Cohort 3 1999–2002 22.0 ± 9.3 15.8 ± 7.6 11.4 ± 5.4 9.3 ± 5.7 <.01
Cohort, p .01 .03 .04 .05BMC Pediatrics 2006, 6:2 http://www.biomedcentral.com/1471-2431/6/2
Page 6 of 8
(page number not for citation purposes)
of the observed increase in the composite outcome of
death and/or severe IVH during the final cohort.
To our knowledge this is the first report of increasing ill-
ness severity in a population of VLBW infants. Our report
is consistent with data from Vermont-Oxford Network
and others who have recently reported no improvement
in survival of VLBW infants during the 1990's [1-3].
Although the reasons behind these plateaus in survival
rates were not clear, it has been hypothesized that neona-
tal care has reached its limits. In our population of VLBW
infants, the increase in severe IVH was temporally associ-
ated with an increase in illness severity as quantified by
both SNAP and T4. Our data suggest that a majority of the
increase in the combined outcome of death and severe
IVH could potentially be accounted for by increasing ill-
ness. In addition, VLBW infants who died during the 3rd
Cohort (1999–2002), died at an earlier time compared to
the first 2 cohorts. The increased illness severity, docu-
mented on the 1st day of life by SNAP scores, and the ear-
lier time of death, suggest an antenatal or perinatal
etiology for the observed increase in illness.
We speculate that a decrease in fetal death rate has
resulted in an increased number of compromised infants
and an increase in neonatal illness. Fetal compromise has
previously been shown to be associated with neonatal
death [20]. In our study sample, there was an increase in
cesarean delivery, antibiotics, and steroids over time as
has been observed in other recent studies [1,9,21].
Despite these obstetrical interventions, we observed no
improvement in survival and increase in severe IVH, one
of the major morbidities in VLBW infants over time.
Changes in perinatal management of VLBW infants, in an
attempt to aggressively care for pregnancies that may have
previously been considered non-viable from a medical or
gestational age stand-point, may be contributing to the
decrease in fetal mortality and subsequent increase in
neonatal illness. Alternatively, the observed increase in ill-
ness severity may be attributed to other factors, which we
were unable to quantify in this study, such as increasing
maternal stressors in the antenatal period. The fact that
survival rates have remained consistent despite increasing
illness suggests that neonatal care may be continuing to
advance but not at a rate fast enough to overcome a steady
increase in illness severity. Although the VLBW infants in
Cohort 3 had a similar occurrence of death compared to
the older cohorts, increasing illness may be contributing
to an increase in neonatal morbidities such as severe IVH
in survivors. Consistent with our study, other important
neonatal morbidities including bronchopulmonary dys-
plasia [9], retinopathy of prematurity [22] and neurode-
velopmental disabilities [21] have all been recently shown
to be increasing in surviving preterm infants.
The present investigation used T4 as a proxy for illness as
we and others have previously shown the association of T4
and illness severity [11-13]. We feel that T4 is a valid
marker of illness severity as confirmed by the inverse cor-
relation between SNAP and T4 in our study sample. Previ-
ous research has shown equivalent ROC curves for T4 and
SNAP in relationship to the outcomes of severe IVH and
death [11]. In support of the fact that T4 is a marker for ill-
ness severity, rather than an important part of the causal
pathway, studies of thyroxine supplementation in pre-
term infants have failed to improve neonatal outcomes
[11,23-25]. Because T4 was measured on the 5th day of life,
we can not rule out the possibility that early management
of VLBW infants may have influenced illness severity and
T4. This possibility, however, remains unlikely as manage-
ment strategies did not change dramatically at our center
during the study period. The use of dopamine, which
inhibits thyroid stimulating hormone production [19],
did increase over time. However, increasing dopamine use
would be expected with an increase in illness and would
not explain an increase in SNAP. It also remains a possi-
bility that low T4 is an important part of the causal path-
way in illness severity and that some primary change in
thyroid function over time in our population contributed
to the observed increase in illness severity. Even if a pri-
mary decrease in T4 was responsible for the observed
increase in illness, the importance of a progressive
decrease in T4  is highlighted by the association of
hypothyroxinemia with death [26], IVH [27], cystic periv-
entricular leukomalacia [28], and cerebral palsy [29] in
VLBW infants.
Our study has a number of other important limitations.
First, since our study sample was from a single region our
findings may not apply to other populations. Replication
of these analyses from other regions would be needed to
determine whether the observed increase in neonatal ill-
ness is occurring elsewhere. Our study is also limited by
the unavailability of SNAP on infants born during the 1st
Cohort and the unavailability of T4 on those infants who
died prior to the 5th day of life. However, those infants
who died prior to thyroid screening would have been
expected to have an increase in illness severity compared
to infant who survived. Thus our data may have poten-
tially underestimated the trend of increasing illness.
Because a small number of infants with birth weight
between 1250 and 1500 grams are cared for at other cent-
ers in the state of Delaware they were not included in this
analysis. There were no changes in the number of hospital
providing neonatal intensive care or maternal-fetal medi-
cine services during the study duration. Furthermore, the
increased illness in our region was present in infants
<1000 grams, all of which were captured in this study
sample. Because all infants <1000 grams born in the state
of Delaware during the study period were captured in ourBMC Pediatrics 2006, 6:2 http://www.biomedcentral.com/1471-2431/6/2
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cohorts it is unlikely that any changes in referral patterns
influenced the results. Although the number of infants
<1500 grams increased in our neonatal intensive care unit
over time, the proportion of infants <1000 grams did not
change over time. Multivariate modeling also adjusted for
changes in gestation over time. We can not conclusively
rule out the possibility that head ultrasounds were inter-
preted differently over time. Our data however are from a
single center with uniform ordering of cranial sonograms
and definitions of severe IVH. Although we were able to
look at many variables influencing illness severity includ-
ing clinical chorioamnionitis, there may have been other
variables such as histologic chorioamnionitis [30] or time
of birth [31] which we were unable to explore. Finally,
although also unlikely, we can not rule out a change in the
quality of obstetrical or neonatal care as a cause for
increasing death on/or severe IVH. The similarities in the
distribution of Apgar scores over time do not suggest that
any changes in early delivery room management are
responsible for the observed outcomes. The drop in the
standardized rate observed over time suggests an improve-
ment in neonatal outcomes, given the magnitude of
increased illness severity.
Recent national data have shown that mortality in VLBW
infants is no longer declining despite advances in neona-
tal care [1-3]. Our data are important in showing an
increase in illness severity over a 9-year period in VLBW
infants. We were also able to document an associated
decrease in the fetal death rate during this same period.
Infant mortality in the United States has been reported to
have increased for the 1st time since 1958 [5]. Similar to
our regional findings, the recent increase in infant mortal-
ity in the United States was associated with a decrease in
the fetal death rate [5]. Based on our data we can not
determine the cause of the observed increase in illness in
VLBW infants, but speculate that there maybe a shift of
fetal deaths to live, but severely physiologically compro-
mised newborns. Future investigations and other regional
data analysis will be necessary to confirm these findings.
List of abbreviations
IVH Intraventricular hemorrhage
NICU Neonatal Intensive Care Unit
SNAP Score for neonatal acute physiology
T4 Total thyroxine
VLBW Very low birth weight
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